LKS

N-[(1Z)-2-phenylethanimidoyl]-5-thio-alpha-D-mannopyranosylamine

Created:	2003-10-08
Last modified:	2020-07-17

Find Related PDB Entry
1 entries where LKS is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	41
Chiral Atom Count	5
Bond Count	42
Aromatic Bond Count	6

2D diagram of LKS

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[(1Z)-2-phenylethanimidoyl]-5-thio-alpha-D-mannopyranosylamine
Synonyms	N-(1-IMINIO-2-PHENYLETHYL)-5-THIOHEXOPYRANOSYLAMINE BROMIDE; 2-C-PHENYL-N-(5-THIO-A/B-D-MANNOPYRANOSYL)ACETAMIDINIUM; N-[(1Z)-2-phenylethanimidoyl]-5-thio-alpha-D-mannosylamine; N-[(1Z)-2-phenylethanimidoyl]-5-thio-D-mannosylamine; N-[(1Z)-2-phenylethanimidoyl]-5-thio-mannosylamine
Systematic Name (OpenEye OEToolkits)	2-phenyl-N-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)thian-2-yl]ethanimidamide
Formula	C₁₄ H₂₀ N₂ O₄ S
Molecular Weight	312.385
Type	D-SACCHARIDE

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	[N@H]=C(NC1SC(C(O)C(O)C1O)CO)Cc2ccccc2
SMILES	CACTVS	3.341	OC[CH]1S[CH](NC(=N)Cc2ccccc2)[CH](O)[CH](O)[CH]1O
SMILES	OpenEye OEToolkits	1.5.0	[H]N=C(Cc1ccccc1)NC2C(C(C(C(S2)CO)O)O)O
Canonical SMILES	CACTVS	3.341	OC[C@H]1S[C@H](NC(=N)Cc2ccccc2)[C@@H](O)[C@@H](O)[C@@H]1O
Canonical SMILES	OpenEye OEToolkits	1.5.0	[H]/N=C(/Cc1ccccc1)\N[C@@H]2[C@H]([C@H]([C@@H]([C@H](S2)CO)O)O)O
InChI	InChI	1.03	InChI=1S/C14H20N2O4S/c15-10(6-8-4-2-1-3-5-8)16-14-13(20)12(19)11(18)9(7-17)21-14/h1-5,9,11-14,17-20H,6-7H2,(H2,15,16)/t9-,11-,12+,13+,14+/m1/s1
InChIKey	InChI	1.03	WKJQYOUTPMBFSL-CYDRSHDDSA-N

Related Resource References

Resource Name	Reference
PubChem	448268, 9547888, 5478839

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.